Fig 1: (A) TUNEL assay was conducted on aortic root sections from male and female mice treated with PPE or vehicle to determine the number of dead cells in the atherosclerotic plaque. Bar, 50 μm (B) In-situ efferocytosis assay was conducted by immunostaining macrophages with anti-F4/80 antibody (red) and dead cells using TUNEL reagent (green). The number of TUNEL + nuclei that were either associated with an F4/80 + macrophage (white arrow) or were lying free (white arrowheads) was quantified. The associated: free ratio was used as a measure of lesional macrophage efferocytosis efficiency. Bar, 10 µm (C) Immunostaining of aortic root sections with anti-F4/80 and anti-Mertk antibody. The mean fluorescence intensity of the staining was quantified in ImageJ by drawing an ROI around the F4/80 + intimal region of the plaque. Bar, 50 µm. Non-parametric Mann-Whitney U test was conducted to determine statistical significance. *, p < 0.05; **, p < 0.01.
Fig 2: Tumor vasculature and components of stroma in lung tumors are targeted by anti-angiogenesis. Formalin fixed paraffin embedded lung sections (5 μm) stained with anti-CD31 (endothelial cells), anti-desmin (smooth muscle cells), anti-F4-80 (macrophages), anti-VEGFR1 and anti-VEGFR2 as described in the materials and methods. The slides were scanned on Nanozoomer instrument using 20× magnification. Irrespective of treatment, AIs treated lungs showed lower CD31 and desmin density. F4-80 staining in vehicle treated mice showed greater infiltration of macrophages. However, AIs particularly axitinib and sunitinib significantly reduced macrophage infiltration in the tumors. AIs had differential effects on VEGFR1 and VEGFR2 expression since all treatments reduced VEGFR2 expression in the tumor vasculature, VEGFR1 expression was mainly inhibited by PF-210 and sunitinib. Pictures are the representative images of each staining from each treatment.
Fig 3: Aortic root sections from male and female mice treated with PPE or vehicle were immunostained with (A) anti-F4/80 antibody (B) anti-CD3 antibody, or (C) anti-smooth muscle actin antibody followed by fluorescence microscopy for imaging. The number of F4/80+ (macrophages), sm-actin + (smooth muscle cells), and CD3+ (T-cells) cells in control or PPE-treated groups were quantified using ImageJ. The dotted lines demarcate the intimal region. Bar, 50 μm n = 5 mice per group per sex. Analysis of statistical significance was conducted by Mann-Whitney test. *, p < 0.05; **, p < 0.01.
Fig 4: Conditional knockout of IGF2 in hepatocyte accelerated d-gal-induced liver aging. The expression levels of IGF2 were examined by Western blotting (A) and RT‒qPCR (B). Liver function evaluated by ALT (C) and AST (D). E Western blotting analysis for the protein level of senescence-associated genes P53, P21 and P16 in the liver tissues. The quantitative data are presented. F Relative mRNA expression levels of senescence-associated secretory phenotype genes IL-6, IL-1β, TNF-α and NF-κB1 in the liver tissues, as measured by RT‒qPCR. G SA-β-gal staining of liver sections. β-gal staining area analysis was shown. Scale bar, 100 um. H H&E staining of liver sections. Scale bar, 50 um. I Immunofluorescent staining of F4/80 and DAPI on liver sections. Fluorescence intensity analysis was shown. Scale bar, 50 um. A–F n = 5–7 per group, G–I n = 3 per group. All values are shown as means ± SEM. Dots represent individual level data. One-way ANOVA was used for comparison among multiple groups. *P < 0.05, **P < 0.01, ***P < 0.001
Supplier Page from Thermo Fisher Scientific for F4/80 Antibody Biotin